Insmed jumps after Sanofi reportedly weighs takeover
SNY•Insmed shares jumped 17% after Sanofi reportedly weighed acquiring the US drugmaker, according to a report. The shares rose to $140.25.
SNY•Insmed shares jumped 17% after Sanofi reportedly weighed acquiring the US drugmaker, according to a report. The shares rose to $140.25.
Insmed shares jumped 17% to $140.25 after a report said Sanofi was weighing an acquisition of the US drugmaker, citing people familiar with the matter. Insmed was on track for its biggest daily percentage gain since August and its highest close since April.